Samsung has followed the example of Apple and launched a smartwatch with a focus on improving the wearer’s health. But unlike its rival, which has marketed a watch that provides an electrocardiogram function, Samsung has opted to provide a feature that measures a wearer’s blood pressure. Starting on 15 March, users will be able to download My BP Lab, a research app jointly developed with the University of California, San Francisco to their Galaxy Watch Active. Samsung said the app wi...
READ MORE
|
Meag Munich Ergo Kapitalanlagegesellschaft MBH purchased a new position in shares of Takeda Pharmaceutical Co Ltd (NYSE:TAK) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 97,965 shares of the company’s stock, valued at approximately $2,022,000. A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Hudock Capital ...
READ MORE
|
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has convened an Expert Working Group (EWG) to assess the risks and benefits of opioid medicines and see if current UK regulation is up to scratch. The opioid addiction crisis in the US has been linked with hundreds of thousands of deaths, with the Trump administration declaring it a national public health emergency. Though the problem is not quite as acute in the UK, the use of opioid painkillers such as codeine and fentan...
READ MORE
|
CStone Pharmaceuticals declared today a permitting concurrence with Lego Chem Bio sciences, Inc, for the turn of events and commercialization of LCB71, a likely first-in-class/top tier immunizer drug form ("ADC").
Under the understanding, CStone gets the selective worldwide option to lead advancement and commercialization of LCB71 outside the Republic of Korea. LCB will get a forthright installment of US$10 million, and up to US$353.5 million in combined achievement inst...
PRNEWSWIRE
READ MORE
|
Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study. The drugs - called cilostazol and isosorbide mononitrate - are already used to treat other conditions, such as heart disease and angina. This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia. A study involving more than 50 stroke patients found that patients tolerated the drugs,...
READ MORE
|
The organization Patients for Affordable Drugs launched a campaign to share the stories of Americans who struggle to cover the cost of their prescriptions and who are hoping to find a solution to lower drug prices....
READ MORE
|